Rochester, New York 12/29/2009 8:05:00 AM
News / Business

Accuray Incorporated (NASDAQ:ARAY) to Present at JP Morgan Healthcare Conference January 13

Accuray Incorporated (NASDAQ:ARAY) will speak at the 28th Annual JP Morgan Healthcare Conference on Wednesday, January 13.  Representing the company will be Accuray President and chief Executive Officer Euan Thomson, Ph.D.  He will begin his presentation at 9:30 am PT that morning. 

 

Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.

 

Interested parties may listen to a webcast of the presentation on the company’s website, http://www.accuray.com/.  The webcast will be on the investor relations portion of the website.  The webcast will remain on the site as a replay for thirty days following the end of the event.

 

Accuray Incorporated has developed an intelligent robotic radiosurgery system, the CyberKnife system, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery. The CyberKnife system represents the next generation of radiosurgery systems, combining continuous image-guidance technology with a compact linear accelerator (linac) that has the ability to move in three dimensions according to a patient’s treatment plan. The Company’s image-guidance technology continuously acquires images to track a tumor’s location and transmits any position corrections to the robotic arm prior to delivery of each dose of radiation.

 

Follow us on Twitter: http://www.twitter.com/pennystockspro

 

Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.

 

About Us

 

Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.

 

Please click here to read the full disclaimer.